Zoi Vasiliki, Galani Vasiliki, Lianos Georgios D, Voulgaris Spyridon, Kyritsis Athanasios P, Alexiou George A
Neurosurgical Institute, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.
Department of Anatomy Histology-Embryology, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.
Biomedicines. 2021 Aug 26;9(9):1086. doi: 10.3390/biomedicines9091086.
Curcumin is a polyphenol extracted from the rhizomes of the turmeric plant, which has anti-inflammatory, and anticancer properties. Chronic inflammation is associated with the development of cancer. Curcumin acts on the regulation of various immune modulators, including cytokines, cyclooxygenase-2 (COX-2), and reactive oxygen species (ROS), which partly explains its anticancer effects. It also takes part in the downregulation of growth factors, protein kinases, oncogenic molecules and various signaling pathways, such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), c-Jun N-terminal kinase (JNK) and signal transducer and activator of transcription 3 (STAT3) signaling. Clinical trials of curcumin have been completed or are ongoing for various types of cancer. This review presents the molecular mechanisms of curcumin in different types of cancer and the evidence from the most recent clinical trials.
姜黄素是从姜黄植物的根茎中提取的一种多酚,具有抗炎和抗癌特性。慢性炎症与癌症的发生发展有关。姜黄素作用于多种免疫调节因子的调控,包括细胞因子、环氧化酶 -2(COX -2)和活性氧(ROS),这部分解释了其抗癌作用。它还参与生长因子、蛋白激酶、致癌分子以及各种信号通路的下调,如核因子κB(NF -κB)、c -Jun氨基末端激酶(JNK)和信号转导及转录激活因子3(STAT3)信号通路。姜黄素针对各类癌症的临床试验已经完成或正在进行。本综述介绍了姜黄素在不同类型癌症中的分子机制以及最新临床试验的证据。